Biogen (BIIB) Raw Materials (2010 - 2018)

Biogen (BIIB) has reported Raw Materials for 9 consecutive years, with $196.3 million the latest figure, recorded in Q4 2018.

• In Q4 2018, Raw Materials rose 20.87% year-over-year to $196.3 million; the TTM figure through Dec 2018 stood at $196.3 million (up 20.87% YoY), while the FY2018 annual figure was $196.3 million, up 20.87% from the prior year.
• Raw Materials came in at $196.3 million for Q4 2018 at Biogen, up from $162.4 million in the prior quarter.
• The five-year high for Raw Materials was $213.0 million in Q4 2015, with the low at $128.3 million in Q4 2014.
• Average Raw Materials over 5 years is $174.1 million, with a median of $170.4 million recorded in 2016.
• Across the five-year window, Raw Materials jumped 66.02% in 2015 and decreased 20.0% in 2016, its largest moves.
• Year by year, Raw Materials stood at $128.3 million in 2014, then surged by 66.02% to $213.0 million in 2015, then retreated by 20.0% to $170.4 million in 2016, then decreased by 4.69% to $162.4 million in 2017, then increased by 20.87% to $196.3 million in 2018.
• According to Business Quant data, Raw Materials over the past three periods registered $196.3 million, $162.4 million, and $170.4 million for Q4 2018, Q4 2017, and Q4 2016 respectively.